Oocyte Maturation Apparatus Using ML-Driven Protocol Assignment

Solution Overview

Problem

Current methods for in vitro oocyte maturation face challenges in maintaining oocyte health and quality, leading to low oocyte quality and discarded immature oocytes, limiting the available pool for IVF.

Innovation Solution

An apparatus and method utilizing a computing device with machine learning processes to assign stimulation protocols and scoring metrics for oocyte maturation, incorporating biological sample data to optimize oocyte culture and improve oocyte health, reducing FSH dosing and cycle duration.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional in vitro maturation methods are used, then oocyte maturation can be achieved, but oocyte quality deteriorates and health is compromised

Engineering Contradiction:
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The patent applies parameter changes by dynamically adjusting culture conditions including pH, oxygen concentration, and nutrient composition based on real-time monitoring of oocyte development stages. This enables precise control over maturation processes while maintaining oocyte quality, resolving the contradiction between achieving maturation and preserving quality.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The system implements feedback mechanisms through continuous monitoring of oocyte maturation indicators and automatic adjustment of culture parameters. This closed-loop control ensures optimal maturation conditions are maintained, improving both the reliability of oocyte quality and the precision of maturation control simultaneously.

Inventive Principle:
Principle #23Feedback

2Quantity of substance

If immature oocytes are discarded traditionally, then only high-quality mature oocytes are used, but the available oocyte pool is constricted

Engineering Contradiction:
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The patent applies preliminary action by initiating in vitro maturation of immature oocytes early in the process, allowing them to develop into viable mature oocytes before selection. This expands the available oocyte pool while maintaining quality standards through controlled maturation, resolving the contradiction between quantity and reliability.

Inventive Principle:
Principle #10Preliminary action

3Productivity

If standard FSH dosing protocols are used, then oocyte stimulation is achieved, but cycle duration is extended and resource consumption increases

Engineering Contradiction:
Core Design Contradiction:
ProductivityVSDuration of action of moving object

Solution Approach 1:

The patent applies periodic action by using pulsed or cyclical FSH dosing regimens combined with real-time monitoring of oocyte response. This allows for reduced total FSH dosage while maintaining effective stimulation, thereby shortening cycle duration and improving productivity without compromising oocyte development.

Inventive Principle:
Principle #19Periodic action

Data Source

PatentUS20240166992A1Apparatus and method for inducing human oocyte maturation in vitro
Publication Date: 2024.05.23
  • US20240166992A1 patent drawing
  • US20240166992A1 patent drawing
  • US20240166992A1 patent drawing

AI summary

An apparatus and method for inducing human oocyte maturation in vitro, the apparatus including: a computing device, wherein the computing device includes at least a processor; and a memory communicatively connected to the at least processor, the memory containing instructions configuring the at least processor to receive first biological sample data from a first biological sample relating to a user; assign the user to a stimulation protocol as a function of the first biological sample; receive second biological sample data from a second biological sample relating to the user wherein the second biological sample comprises at least an immature oocyte; receive culture data relating the second biological sample; and assign the second biological sample a scoring metric as a function of the culture data of the second biological sample.